Loading...
Loading...
SXTP| Name | Value |
|---|---|
| Revenues | 125.7K |
| Cost of Revenue | 89.6K |
| Gross Profit | 36.1K |
| Operating Expense | 4,224.9K |
| Operating I/L | -4,188.7K |
| Other Income/Expense | 15.0K |
| Interest Income | 0.0K |
| Pretax | -4,173.8K |
| Income Tax Expense | 0.4K |
| Net Income/Loss | -4,172.8K |
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies for the prevention and treatment of infectious diseases. The company's flagship product, Arakoda, is a preventative treatment for malaria. Additionally, the company is developing Tafenoquine for various infectious and non-infectious diseases, including a Phase IIb clinical trial for COVID-19, fungal lung infections, tick-borne diseases, and candidiasis. They are also working on Celgosivir for respiratory viruses and dengue. Through the sale and distribution of these innovative therapies, the company generates revenue and aims to address critical unmet medical needs in the infectious disease space.
